(Q42919998)

11 November 2017

title

Potential for pharmacokinetic interactions between ambrisentan and cyclosporine (English)

1 reference

11 November 2017

Potential for Pharmacokinetic Interactions Between Ambrisentan and Cyclosporine (English)

1 reference

DOI

10.1038/CLPT.2010.120

https://api.crossref.org/works/10.1038/CLPT.2010.120

5 July 2024

1 reference

3

D. B. Richards

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20811346

5 July 2024

author name string

R. Spence

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20811346

5 July 2024

A. Mandagere

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20811346

5 July 2024

M. H. Magee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20811346

5 July 2024

C. Dufton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20811346

5 July 2024

R. Boinpally

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20811346

5 July 2024

language of work or name

English

0 references

publication date

1 September 2010

1 reference

Clinical Pharmacology & Therapeutics

11 November 2017

published in

1 reference

11 November 2017

volume

88

1 reference

11 November 2017

issue

4

1 reference

11 November 2017

page(s)

513-520

1 reference

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

Pharmacokinetics and safety of ambrisentan in combination with sildenafil in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

The pharmacokinetics and pharmacodynamics of warfarin in combination with ambrisentan in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

Effect of ketoconazole on the pharmacokinetic profile of ambrisentan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

Role of endothelin in cyclosporine-induced glomerular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

Inhibition of Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake Is the Major Determinant in the Pharmacokinetic Interaction between Bosentan and Cyclosporin A in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

Sex is a major determinant of CYP3A4 expression in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.120

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2010.120

1 reference

11 November 2017

1 reference